FDA Authorizes Abbott’s '$5, 15 Minute' COVID-19 Antigen Test

The BinaxNOW COVID-19 Ag Card portable lateral flow test, which delivers rapid results with no instrumentation, could be a “game changer” in the effort to reopen schools and other crowded places.

Abbott-sign
• Source: shutterstock.com

Abbott expects its new inexpensive point-of-care COVID-19 antigen test will allow for the detection of active COVID-19 infections on a “massive scale.”

On 26 August, the US Food and Drug Administration issued an emergency use authorization for Abbott’s BinaxNOW COVID-19 Ag...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation